Related Experiment Video

Updated: Aug 9, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

[Clinical studies on cefprozil granules]

T Haruta1, T Tsutsui, S Kuroki

  • 1Department of Pediatrics, Kobe City General Hospital.

The Japanese Journal of Antibiotics
|December 1, 1992
PubMed

Insights

Cefprozil granules demonstrated 100% clinical efficacy in pediatric bacterial infections, with no observed side effects. This study highlights its potential as a well-tolerated treatment option for children.

Area of Science:

  • Pediatric Infectious Diseases
  • Pharmacology
  • Bacteriology

Background:

  • Bacterial infections are common in pediatric patients.
  • Effective and safe antimicrobial agents are crucial for treating pediatric infections.
  • Cefprozil is a cephalosporin antibiotic with a broad spectrum of activity.

Purpose of the Study:

  • To evaluate the clinical efficacy and safety of cefprozil granule preparation in pediatric patients with bacterial infections.
  • To assess the bacteriological eradication rates of cefprozil against common pediatric pathogens.

Main Methods:

  • Oral administration of cefprozil granule preparation to 16 pediatric patients (8 months to 9 years 6 months).
  • Daily doses ranged from 29.4 to 35.7 mg/kg, divided into 3 or 4 doses.
  • Clinical efficacy, bacteriological response, and adverse events were monitored.

Main Results:

  • Overall clinical efficacy rate was 100% (9 excellent, 7 moderate).
  • Bacteriological eradication rate was 68.8% against 17 pathogen strains, including Haemophilus influenzae, Streptococcus pyogenes, and Staphylococcus aureus.
  • No significant side effects were observed; abnormal laboratory findings were transient and not clinically significant.
  • Palatability was not an issue, with no drug refusal due to taste or odor.

Conclusions:

  • Cefprozil granule preparation is highly effective and well-tolerated for treating pediatric bacterial infections.
  • The drug demonstrated a favorable safety profile and good palatability in the pediatric population.
  • Cefprozil shows promise as a valuable therapeutic option for pediatric bacterial infections.

More Related Videos

Multi-scale Analysis of Bacterial Growth Under Stress Treatments12:08

Multi-scale Analysis of Bacterial Growth Under Stress Treatments

Published on: November 28, 2019

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...